Small Interfering RNA Therapeutics in Hypertension: A Viewpoint on Vasopressor and Vasopressor‐Sparing Strategies for Counteracting Blood Pressure Lowering by Angiotensinogen–Targeting Small Interfering RNA

Priyanga Ranasinghe, Melisande L. Addison, David J. Webb*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
Article numbere027694
Number of pages6
JournalJournal of the American Heart Association
Issue number20
Publication statusPublished - 10 Oct 2022


  • angiotensinogen
  • hypertension therapy
  • reversibility
  • siRNA
  • zilebesiran

Cite this